Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:NVTA

Invitae (NVTA) Stock Price, News & Analysis

Invitae logo

About Invitae Stock (NYSE:NVTA)

Advanced Chart

Key Stats

Today's Range
$0.0003
$0.0003
50-Day Range
N/A
52-Week Range
$0.02
$0.02
Volume
75 shs
Average Volume
23.72 million shs
Market Capitalization
$80.10 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Invitae Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
24th Percentile Overall Score

NVTA MarketRank™: 

Invitae scored higher than 24% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Invitae.

  • Earnings Growth

    Earnings for Invitae are expected to grow in the coming year, from ($1.05) to ($0.89) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Invitae is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Invitae is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Invitae has a P/B Ratio of 0.00. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for NVTA.
  • Dividend Yield

    Invitae does not currently pay a dividend.

  • Dividend Growth

    Invitae does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for NVTA.
  • Search Interest

    3 people have searched for NVTA on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Invitae insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.74% of the stock of Invitae is held by insiders.

  • Percentage Held by Institutions

    61.28% of the stock of Invitae is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Invitae's insider trading history.
Receive NVTA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Invitae and its competitors with MarketBeat's FREE daily newsletter.

NVTA Stock News Headlines

Presidential Bombshell: $150T Resource to Be Released as soon as this Summer?
Something extraordinary is happening in Washington. For the first time in over a century, a sitting President could release a national treasure that's been tied up in red tape, for generations. I'm talking about a $150 trillion American asset that's scattered across all 50 states. While the mainstream media focuses on political theater, this story is quietly developing behind closed doors.
Labcorp to acquire Invitae assets for $239 million
Labcorp wins $239M bid for bankrupt Invitae
See More Headlines

NVTA Stock Analysis - Frequently Asked Questions

Invitae Co. (NYSE:NVTA) posted its earnings results on Tuesday, May, 9th. The medical research company reported ($0.37) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.41) by $0.04. The firm's quarterly revenue was down 5.1% on a year-over-year basis.

Invitae (NVTA) raised $76 million in an IPO on Thursday, February 12th 2015. The company issued 5,400,000 shares at a price of $13.00-$15.00 per share. J.P. Morgan acted as the underwriter for the IPO and Cowen and Company and Leerink Partners were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Invitae investors own include NVIDIA (NVDA), Tesla (TSLA), Meta Platforms (META), CrowdStrike (CRWD), Teladoc Health (TDOC) and PayPal (PYPL).

Company Calendar

Last Earnings
5/09/2023
Today
8/10/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Medical laboratories
Sub-Industry
N/A
Current Symbol
NYSE:NVTA
CIK
1501134
Fax
N/A
Employees
1,700
Year Founded
2010

Profitability

EPS (Trailing Twelve Months)
($5.38)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$3.11 billion
Net Margins
-299.14%
Pretax Margin
-301.93%
Return on Equity
-6,100.71%
Return on Assets
-19.68%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.39
Quick Ratio
2.25

Sales & Book Value

Annual Sales
$481.58 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.42 per share
Price / Book
0.00

Miscellaneous

Outstanding Shares
267,010,000
Free Float
284,373,000
Market Cap
$80.10 thousand
Optionable
Optionable
Beta
1.59

Social Links

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NYSE:NVTA) was last updated on 8/10/2025 by MarketBeat.com Staff
From Our Partners